文献速递前列腺增生与排尿功能障碍小儿泌尿与泌尿修复

Williams-Beuren综合征儿童下尿路症状的纵向改善

Longitudinal Improvement of Lower Urinary Tract Symptoms in Williams-Beuren Syndrome.
PubMed 文献 · J Urol · 2020-12-24

本研究评估了Williams-Beuren综合征儿童下尿路症状的长期结局,31例随访≥5年的患儿中基线27例(87.1%)有症状,中位随访10年,药物疗程中位7年,5年和10年时仍用药者分别61.2%和52.9%,症状显著改善(5年35.5%、10年29.5%有症状,p<0.001),生活质量也显著提高(p<0.001)。

要点

  • Williams-Beuren综合征患儿下尿路症状高发,基线87.1%有症状。
  • 长期药物治疗常见,5年和10年仍用药者分别61.2%和52.9%。
  • 症状和生活质量随时间显著改善,但多数需长期用药。

核心结论

  • Williams-Beuren综合征儿童和青少年下尿路症状随时间显著改善,但多数患者需要长期药物治疗。

研究设计与样本

  • 回顾性长期随访研究,2001年2月至2016年7月共评估90例Williams-Beuren综合征患者,其中31例(20例男孩)随访至少5年。

主要发现

  • 基线27例(87.1%)有下尿路症状,中位随访10年(范围6-13年)。
  • 基线25例(92.6%)有症状者起始药物治疗:奥昔布宁19例(76.0%)、多沙唑嗪1例(4.0%)、两药联合5例(20.0%)。
  • 5年和10年时仍用药者分别61.2%和52.9%(p=0.043),中位药物治疗 duration 7年(范围6-11年)。
  • 5年和10年时有症状者分别35.5%和29.5%(p<0.001),生活质量显著改善(p<0.001)。

临床怎么用

  • 对Williams-Beuren综合征患儿应评估下尿路症状并考虑长期药物治疗,同时监测症状和生活质量变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Williams-Beuren syndrome is a chromosomal disorder caused by a deletion at region 7q11.23. Lower urinary tract symptoms are highly prevalent and significantly affect quality of life. We assessed the long-term outcomes of lower urinary tract symptoms in children with Williams-Beuren syndrome. MATERIALS AND METHODS: From February 2001 to July 2016, 90 patients with Williams-Beuren syndrome were evaluated in our hospital, of whom 31 (20 boys) had at least 5 years of followup. Baseline evaluation included a history of lower urinary tract symptoms, frequency-volume chart and the impact on quality of life measured on a scale of 0 (delighted) to 6 (terrible). Pharmacological therapy with oxybutynin or doxazosin was offered to symptomatic patients. We present the outcome of lower urinary tract symptoms after 5 and 10 years of followup. RESULTS: At baseline 27 (87.1%) patients were symptomatic. Median duration of followup was 10 (range 6-13) years. Pharmacological therapy was started for 25 (92.6%) symptomatic patients at baseline, including oxybutynin for 19 (76.0%), doxazosin for 1 (4.0%) and a combination of the 2 agents for 5 (20.0%). Medical therapy was still in use by 61.2% after 5 years and 52.9% after 10 years (p=0.043). Median duration of pharmacological treatment was 7 (range 6-11) years. A significant improvement of lower urinary tract symptoms was observed over time, with 35.5% and 29.5% patients considered symptomatic after 5 years and 10 years, respectively (p <0.001). Quality of life was also markedly improved over time (p <0.001). CONCLUSIONS: This long-term study showed significant improvement of lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome over time. Long-term pharmacological treatment was needed in most patients.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Sammour ZM, Hisano M, de Bessa J, et al. Longitudinal Improvement of Lower Urinary Tract Symptoms in Williams-Beuren Syndrome. J Urol. 2020. PMID: 33356485. doi:10.1097/JU.0000000000001560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。